Rankings
▼
Calendar
HOWL FY 2019 Earnings — Werewolf Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
HOWL
Werewolf Therapeutics, Inc.
$41M
FY 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$463,000
Operating Income
-$10M
Net Income
-$11M
EPS (Diluted)
$-0.38
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$10M
Stock-Based Comp.
$559,000
Balance Sheet
Total Assets
$22M
Total Liabilities
$12M
Stockholders' Equity
$10M
Cash & Equivalents
$18M
← Q1 2020
All Quarters
